Who
Marc Odrich
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, LENZ Therapeutics.
In numbers
- Trades disclosed
- 8
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 21 Mar 2024
- Last trade
- 2 Jan 2026
- Last filed
- 6 Jan 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Jan 2026filed 6 Jan 2026 | LENZ LENZ Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —84,200 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | LENZ LENZ Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —14,000 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | LENZ LENZ Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —84,200 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | LENZ LENZ Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —14,000 at $0.00 | filing |
| 9 Jan 2025filed 13 Jan 2025 | LENZ LENZ Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —80,100 at $0.00 | filing |
| 21 Mar 2024filed 25 Mar 2024 | LENZ LENZ Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —66,472 at $0.00 | filing |
| 21 Mar 2024filed 25 Mar 2024 | LENZ LENZ Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —105,000 at $0.00 | filing |
| 21 Mar 2024filed 25 Mar 2024 | LENZ LENZ TherapeuticsBiotechnology | SEC FORM 4 Code A | —99,599 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.